uniQure (QURE) Research & Development (2016 - 2026)
uniQure's (QURE) quarterly Research & Development came in at $29.2 million in Q1 2026, down 19.27% year-on-year from $36.1 million in Q1 2025, and down 16.12% quarter-over-quarter from $34.8 million in Q4 2025.
uniQure (QURE) Research & Development (2016 - 2026) Analysis & Trends
uniQure's Research & Development history runs 11 years deep, the most recent figure standing at $29.2 million for Q1 2026.
- On a quarterly basis, Research & Development fell 19.27% year-over-year to $29.2 million in Q1 2026; TTM through Mar 2026 was $133.7 million, a 3.97% decrease from a year earlier, with the FY2025 full-year figure at $140.7 million, down 2.16% from the prior year.
- Research & Development fell to $29.2 million in Q1 2026 per QURE's latest filing, from $34.8 million in the prior quarter.
- Across five years, Research & Development topped out at $65.4 million in Q3 2023 and bottomed at $29.2 million in Q1 2026.
- The 5-year median for Research & Development is $40.7 million (2024), against an average of $42.7 million.
- Across the five-year window, Research & Development surged 41.06% in 2022 and tumbled 53.22% in 2024, its largest moves.
- Year by year, Research & Development stood at $58.3 million in 2022, then fell by 26.93% to $42.6 million in 2023, then decreased by 8.87% to $38.8 million in 2024, then decreased by 10.44% to $34.8 million in 2025, then dropped by 16.12% to $29.2 million in 2026.
- Per Business Quant, the three latest QURE Research & Development figures stand at $29.2 million (Q1 2026), $34.8 million (Q4 2025), and $34.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | uniQure | 2.42 Bn | 2.42 Bn | 3.34 Mn | 29.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.18 Mn |
| Dec 31, 2025 | 34.78 Mn |
| Sep 30, 2025 | 34.37 Mn |
| Jun 30, 2025 | 35.38 Mn |
| Mar 31, 2025 | 36.14 Mn |
| Dec 31, 2024 | 38.84 Mn |
| Sep 30, 2024 | 30.60 Mn |
| Jun 30, 2024 | 33.66 Mn |
| Mar 31, 2024 | 40.69 Mn |
| Dec 31, 2023 | 42.62 Mn |
| Sep 30, 2023 | 65.40 Mn |
| Jun 30, 2023 | 46.04 Mn |
| Mar 31, 2023 | 60.81 Mn |
| Dec 31, 2022 | 58.33 Mn |
| Sep 30, 2022 | 48.07 Mn |
| Jun 30, 2022 | 46.19 Mn |
| Mar 31, 2022 | 45.00 Mn |
| Dec 31, 2021 | 42.34 Mn |
| Sep 30, 2021 | 36.43 Mn |
| Jun 30, 2021 | 32.75 Mn |